What is NDC 60505-6411?

60505-6411 is the product NDC for Hydrocortisone sodium succinate, Hydrocortisone sodium succinate 100 mg/2mL injection, powder, for solution, listed with the FDA by Apotex Corp.. It has 1 package NDC, shown above in 10- and 11-digit form.

Apotex Corp., NDC labeler code 60505. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Hydrocortisone sodium succinate?

3 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Hydrocortisone sodium succinate NDC 60505-6411

NDC codes

FDA NDC Directory

Product NDC (as listed)60505-6411Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60505-6411Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60505-6411-0	6050564110060505641100	1 VIAL in 1 CARTON (60505-6411-0) / 2 mL in 1 VIALMarketed from Jun 19, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hydrocortisone sodium succinate
Generic name (nonproprietary): hydrocortisone sodium succinate
Active ingredients: Hydrocortisone sodium succinate — 100 mg/2mL
Dosage form: Injection, Powder, For solution
Route: Intramuscular, Intravenous
Labeler: Apotex Corp.NDC labeler code 60505
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219856
Marketing start: Jun 19, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 60505-6411_94e39279-c0ca-657b-da78-1d3ad56ed4afSPL ID 94e39279-c0ca-657b-da78-1d3ad56ed4afSPL set ID bfe185a6-b657-2fbb-4ac2-e085373f15f3RxCUI 238755UNII 50LQB69S1Z
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N460505641100 followed by a unit qualifier and the quantity

Package 60505-6411-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 28, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of hydrocortisone sodium succinate for injection is indicated as follows: Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (S…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 60505-6411

What is NDC 60505-6411?: 60505-6411 is the product NDC for Hydrocortisone sodium succinate, Hydrocortisone sodium succinate 100 mg/2mL injection, powder, for solution, listed with the FDA by Apotex Corp.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Hydrocortisone sodium succinate.
What is the active ingredient?: Hydrocortisone sodium succinate.
Who is the labeler?: Apotex Corp., NDC labeler code 60505. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Hydrocortisone sodium succinate?: 3 other product NDCs are listed under this name. See all Hydrocortisone sodium succinate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Hydrocortisone sodium succinate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Hydrocortisone sodium succinate	Hydrocortisone sodium succinate 100 mg/2mL	InjectionIntramuscular, Intravenous	Zydus Pharmaceuticals USA Inc.	70710-1907	70710-1907-01
Hydrocortisone sodium succinate	Hydrocortisone sodium succinate 100 mg/2mL	InjectionIntramuscular, Intravenous	Zydus Lifesciences Limited	70771-1966	70771-1966-01
Hydrocortisone sodium succinate	Hydrocortisone sodium succinate 100 mg/2mL	InjectionIntramuscular, Intravenous	Cipla USA Inc.	69097-004	69097-0004-67